Xu Jing Selected Research

levamlodipine

1/2020

Characterizing the critical features when personalizing antihypertensive drugs using spectrum analysis and machine learning methods.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xu Jing Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 01/2020
7	Schistosomiasis (Bilharziasis) 04/2019 - 05/2016
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
3	Breast Neoplasms (Breast Cancer) 12/2021 - 07/2019
3	Stroke (Strokes) 04/2015 - 12/2013
2	Fibrosarcoma 01/2020 - 04/2015
2	Plague (Bubonic Plague) 04/2019 - 02/2018
2	Atherosclerosis 01/2019 - 05/2013
2	Brain Ischemia (Cerebral Ischemia) 09/2017 - 07/2014
2	Parkinson Disease (Parkinson's Disease) 04/2016 - 04/2014
1	Inflammation (Inflammations) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Triple Negative Breast Neoplasms 12/2021
1	Melanoma (Melanoma, Malignant) 11/2021
1	Type 2 Diabetes Mellitus (MODY) 09/2021
1	Insulin Resistance 09/2021
1	Hepatocellular Carcinoma (Hepatoma) 09/2021
1	Reperfusion Injury 02/2021
1	COVID-19 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Premature Birth (Birth, Premature) 10/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Cholangiocarcinoma 01/2020
1	Vascular Remodeling 01/2020
1	Adenocarcinoma of Lung 02/2019
1	Neuroinflammatory Diseases 02/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Proteinuria 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Overactive Urinary Bladder (Overactive Bladder) 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019
1	Granuloma 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

5	AntioxidantsIBA 01/2020 - 12/2013
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2013
4	Pharmaceutical PreparationsIBA 01/2021 - 12/2016
3	Long Noncoding RNAIBA 01/2022 - 02/2019
3	EnzymesIBA 09/2021 - 12/2013
3	Neuroprotective AgentsIBA 04/2016 - 07/2014
2	Interleukin-33IBA 01/2022 - 11/2021
2	AntigensIBA 11/2021 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2020
2	Biological ProductsIBA 01/2020 - 01/2018
2	Monoamine Oxidase (MAO)IBA 04/2019 - 02/2018
2	Therapeutic UsesIBA 05/2017 - 04/2016
1	Leucine (L-Leucine)FDA Link 01/2022
1	Collagen Type III (Type III Collagen)IBA 01/2022
1	Interleukin-8B ReceptorsIBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	ProteomeIBA 12/2021
1	Estrogen Receptor alphaIBA 12/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2021
1	human ERBB2 proteinIBA 12/2021
1	Surface Antigens (Surface Antigen)IBA 11/2021
1	Histocompatibility Antigens Class IIBA 11/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 09/2021
1	MibefradilIBA 09/2021
1	PalmitatesIBA 09/2021
1	Glucose (Dextrose)FDA LinkGeneric 09/2021
1	GlycogenIBA 09/2021
1	Insulin (Novolin)FDA Link 09/2021
1	Blood Glucose (Blood Sugar)IBA 09/2021
1	Cisplatin (Platino)FDA LinkGeneric 02/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Toll-Like Receptor 2IBA 10/2020
1	levamlodipineIBA 01/2020
1	Irbesartan FDA LinkGeneric 01/2020
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2020
1	Felodipine (Agon)FDA LinkGeneric 01/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2020
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2020
1	CaspasesIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	PeroxiredoxinsIBA 01/2020
1	Ubiquitin-Specific ProteasesIBA 01/2020
1	paeonolIBA 07/2019
1	Interleukin-6 (Interleukin 6)IBA 02/2019
1	Biomarkers (Surrogate Marker)IBA 02/2019
1	Mitochondrial Uncoupling ProteinsIBA 01/2019
1	mirabegronIBA 01/2019
1	LDL Receptors (LDL Receptor)IBA 01/2019
1	Serum AlbuminIBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	ApolipoproteinsIBA 01/2019
1	LDL CholesterolIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	CateninsIBA 01/2018
1	Cholinergic Agents (Cholinergics)IBA 09/2017
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2017
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 09/2017

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 10/2018 - 12/2016
2	Therapeutics 01/2022 - 01/2020
1	Immunotherapy 01/2020
1	Precision Medicine 01/2020
1	Oral Administration 01/2019